Now showing items 1-10 of 120
The lipodystrophy syndrome as a risk marker for cardiovascular disease in patients with HIV/AIDS treated with HAART
Introduction: The classic risk factors for cardiovascular disease in healthy individuals are well known, however, it lacks in the literature the mechanisms that predicts cardiovascular disease in the population living with ...
Cytokine profile and clinical metabolic alterations in HIV-1 infected individuals with and without lipodistrophy
The extensive use of Highly Active Antiretroviral Therapy (HAART) has transformed HIV infection into a chronic condition. Thus, metabolic alterations including lipodystrophy and dyslipidemia have been associated with the ...
Development and analysis of formulations to the delivery of caffeine for the treatment of gynoid lipodystrophy
This study aimed to investigate the kinetics of the in vitro release of caffeine in various excipients, and to perform the rheological characterization of these excipients. In vitro release experiments were performed using ...
Body composition and lipodystrophy in prepubertal HIV-infected children
(Brazilian Society of Infectious Diseases, 2013-02-01)
OBJECTIVE: To identify lipodystrophy in prepubertal HIV-infected children using anthropometric parameters and body composition assessment. METHODS: Cross-sectional study including 40 prepubertal HIV-infected children of ...
Cytokines profile and clinical-metabolic alterations in HIV-1-infected individuals with and without lypodistrophy
Highly active antiretroviral therapy (HAART) has lead to a dramatic decrease in the morbidity of patients infected with HIV. However, metabolic side effects, including lipodystrophy and dyslipidemia, have been reported in ...